SCHEMBL17016204

SCHEMBL17016204

c1ccc(-n2c3ccccc3c3ccc4ccn(-c5ccc6c7ccccc7c7ccccc7c6c5)c4c32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ATM Q13315 1/20 0.45
MAPK8 P45983 2/20 0.33
MAPK9 P45984 1/20 0.33
PGR P06401 1/20 0.33
MAPK1 P28482 2/20 0.33
HKDC1 Q2TB90 1/20 0.32
HTT P42858 2/20 0.32
BIRC5 O15392 1/20 0.32
PTPN1 P18031 1/20 0.32
KMT2A Q03164 2/20 0.31
IL1R1 P14778 1/20 0.31
ALDH1A1 P00352 2/20 0.31
TSHR P16473 1/20 0.31
KDR P35968 1/20 0.30
SIGMAR1 Q99720 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015328 0.95 KDM4E (0.41) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL17016208 0.93 L3MBTL1 (0.39) KDM4EL3MBTL1ATMHTTKMT2A
SCHEMBL15631987 0.92 KDM4E (0.50) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL16357581 0.91 KDM4E (0.44) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL16357583 0.90 KDM4E (0.53) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL16357306 0.90 KDM4E (0.53) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL15213666 0.90 KDM4E (0.52) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL15989366 0.90 L3MBTL1 (0.41) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL17015332 0.90 L3MBTL1 (0.41) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL17016213 0.90 KDM4E (0.42) KDM4EL3MBTL1ATMMAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 KDM4E 1286/4885L3MBTL1 533/4885ATM 3623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.